Complete Filing Data
AdaptHealth Corp. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $1.53 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean AdaptHealth Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$70.8M | $90.4M | -$678.9M | $69.3M | $156.2M | -$161.6M | -$21.3M | $23.3M | -$693.00 |
| Income Tax Expense Benefit | $50.9M | $41.2M | -$49.0M | $24.8M | $32.8M | -$12.0M | $739.0K | -$2.1M | |
| Operating Income Loss | $90.9M | $263.7M | -$598.4M | $190.4M | $225.6M | $71.3M | $29.4M | $31.1M | -$693.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$15.2M | $136.0M | -$723.8M | $97.9M | $191.0M | -$206.0M | -$21.9M | $22.2M | -$693.00 |
| General And Administrative Expense | $382.3M | $359.2M | $334.6M | $324.8M | $167.5M | $89.3M | $56.5M | $18.1M | $693.00 |
| Net Income Loss Attributable To Noncontrolling Interest | $4.8M | $4.4M | $4.1M | $3.8M | $2.0M | -$32.5M | -$1.3M | $1.1M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $3.24B | $3.26B | $3.20B | $2.97B | $2.45B | $1.06B | $529.6M | $345.3M | |
| Cost Of Goods And Services Sold | $2.64B | $2.58B | $2.58B | $2.39B | $2.01B | $898.6M | $440.7M | $293.4M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$68.2M | $92.7M | -$679.1M | $84.2M | $163.9M | -$204.8M | -$20.1M | $24.3M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $4.8M | $4.4M | $4.1M | $3.8M | $2.0M | -$32.5M | -$1.3M | $1.1M | |
| Comprehensive Income Net Of Tax | -$73.0M | $88.3M | -$683.2M | $80.4M | $162.0M | -$172.3M | -$18.8M | $23.3M | |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -$2.2M | -$2.1M | -$4.3M | $11.0M | $5.8M | -$10.7M | $2.5M | ||
| Other Nonoperating Income Expense | -$274.0K | -$2.8M | -$29.6M | -$253.0K | -$1.8M | $3.4M | $318.0K | ||
| Interest Expense | $130.3M | $109.4M | $95.2M | $41.4M | $39.3M | $7.5M | |||
| Income Taxes Paid Net | $24.3M | $14.1M | $14.8M | $14.9M | $14.8M | $7.5M | $1.3M | $405.2K | |
| Deferred Income Tax Expense Benefit | $47.2M | $32.0M | -$62.6M | $18.0M | $22.4M | -$21.1M | $478.0K | -$2.9M | |
| Deferred Income Tax Assets Net | $267.8M | $314.5M | $345.9M | $281.8M | $304.2M | $208.4M | $27.9M | $9.1M | |
| Income Loss From Continuing Operations Per Basic Share | $1.12 | -$3.08 | -$0.95 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $24.5M | $14.7M | -$7.2M | $22.9M | $19.4M | -$2.1M | -$454.1M | $14.0M | $15.7M | $16.1M | $14.0M | $41.8M | $58.1M | $79.1M | -$4.0M | -$51.0M | $4.5M | -$34.6M | -$3.7M | -$2.1M | -$5.8M | $518.3K | $689.8K | $220.3K |
| Income Tax Expense Benefit | $10.6M | $35.9M | $850.0K | $8.1M | $7.2M | $6.6M | -$34.6M | $5.4M | -$1.7M | $5.6M | $8.9M | $5.6M | $12.1M | $12.3M | -$1.7M | -$4.9M | $1.8M | -$1.6M | $1.0M | $2.0M | $2.4M | $241.8K | $232.4K | $72.0K |
| Operating Income Loss | $61.7M | $79.3M | $23.2M | $63.5M | $52.0M | $50.5M | -$461.0M | $54.3M | $26.2M | $52.9M | $59.2M | $51.6M | $75.7M | $65.4M | $15.4M | $13.3M | $15.6M | $8.2M | $8.7M | $14.9M | $5.3M | -$444.8K | -$234.4K | -$72.5K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $36.4M | $51.7M | -$5.2M | $32.0M | $27.8M | $5.5M | -$487.5M | $20.4M | $15.0M | $22.8M | $24.1M | $47.8M | $70.4M | $92.4M | -$5.3M | -$66.9M | $9.7M | -$51.1M | -$2.0M | $276.0K | -$3.0M | $760.1K | $922.2K | $292.4K |
| General And Administrative Expense | $90.1M | $97.4M | $86.9M | $87.3M | $99.4M | $89.0M | $45.2M | $50.1M | $47.5M | $40.7M | $42.5M | $41.4M | $33.0M | $42.9M | $56.6M | $26.3M | $17.1M | $14.3M | $12.1M | $6.3M | $13.1M | $391.2K | $162.6K | $50.7K |
| Net Income Loss Attributable To Noncontrolling Interest | $1.2M | $1.2M | $1.1M | $1.1M | $1.1M | $1.0M | $1.2M | $1.1M | $968.0K | $1.1M | $1.2M | $480.0K | $174.0K | $951.0K | $324.0K | -$10.9M | $3.4M | -$14.9M | $627.0K | $361.0K | $348.1K | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $820.3M | $800.4M | $777.9M | $805.9M | $806.0M | $792.5M | $804.0M | $793.3M | $744.6M | $756.5M | $727.6M | $706.2M | $653.3M | $617.0M | $482.1M | $284.4M | $232.1M | $191.4M | $136.5M | $124.2M | $119.5M | |||
| Cost Of Goods And Services Sold | $658.4M | $645.7M | $657.4M | $643.8M | $636.6M | $635.0M | $693.5M | $673.4M | $655.4M | $646.7M | $610.0M | $597.1M | $529.9M | $490.7M | $396.7M | $240.7M | $198.4M | $167.6M | $114.8M | $102.2M | $100.2M | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $25.1M | $15.4M | -$6.8M | $20.7M | $20.2M | -$253.0K | -$452.9M | $17.5M | $13.9M | $25.0M | $16.8M | $48.2M | $58.9M | $80.7M | -$1.8M | -$61.1M | $6.8M | -$60.9M | -$2.2M | -$1.7M | -$5.5M | |||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $1.2M | $1.2M | $1.1M | $1.1M | $1.1M | $1.0M | $1.2M | $1.1M | $968.0K | $1.1M | $1.2M | $480.0K | $174.0K | $951.0K | $324.0K | -$10.9M | $3.4M | -$14.9M | $627.0K | $361.0K | $348.1K | |||
| Comprehensive Income Net Of Tax | $23.9M | $14.3M | -$7.9M | $19.6M | $19.1M | -$1.3M | -$454.0M | $16.4M | $12.9M | $23.9M | $15.6M | $47.7M | $58.7M | $79.8M | -$2.1M | -$50.1M | $3.4M | -$46.0M | -$2.8M | -$2.1M | -$5.8M | |||
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -$604.0K | -$405.0K | -$675.0K | -$3.2M | -$364.0K | $856.0K | $66.0K | $2.5M | -$2.8M | $7.8M | $1.6M | $6.0M | $640.0K | $664.0K | $1.9M | $925.0K | -$1.1M | -$11.4M | $850.0K | |||||
| Other Nonoperating Income Expense | $0.00 | $0.00 | $0.00 | $0.00 | $1.8M | -$5.1M | -$3.3M | -$2.1M | -$1.2M | -$257.0K | -$1.3M | -$5.7M | $452.0K | -$1.7M | $519.0K | $900.0K | $1.1M | |||||||
| Interest Expense | $32.5M | $32.3M | $32.6M | $32.0M | $28.5M | $25.6M | $24.8M | $24.3M | $23.1M | $22.2M | $12.4M | $7.5M | $7.9M | $10.8M | $14.6M | $6.3M | ||||||||
| Income Taxes Paid Net | -$42.0K | -$328.0K | $384.0K | $11.0K | $2.8M | $2.1M | $39.2K | |||||||||||||||||
| Deferred Income Tax Expense Benefit | -$776.0K | $4.4M | -$2.3M | $4.3M | -$1.7M | -$2.3M | $1.5M | |||||||||||||||||
| Deferred Income Tax Assets Net | $267.9M | $302.2M | $315.1M | $328.1M | $333.6M | $341.1M | $318.9M | $280.5M | $285.1M | $286.1M | $292.2M | $299.9M | $293.8M | $303.6M | $311.5M | |||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.11 | $0.10 | $0.29 | $0.40 | $0.56 | -$0.04 | -$0.89 | $0.10 | -$0.82 | -$0.17 | -$0.10 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.52B | $1.57B | $1.46B | $2.15B | $2.06B | $354.9M | -$23.4M | $0.00 | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $106.1M | $109.7M | $77.1M | $46.3M | $149.6M | $100.0M | $76.9M | $25.2M | $4.3M |
| Retained Earnings Accumulated Deficit | -$633.0M | -$562.2M | -$652.6M | $26.3M | -$43.0M | -$199.2M | -$29.3M | -$13.4M | -$693.00 |
| Liabilities | $2.79B | $2.91B | $3.04B | $3.06B | $3.18B | $1.53B | $584.7M | $266.2M | $286.3K |
| Assets | $4.32B | $4.49B | $4.51B | $5.22B | $5.25B | $1.81B | $546.5M | $369.0M | $310.6K |
| Liabilities Current | $712.4M | $567.0M | $537.0M | $456.2M | $499.8M | $422.1M | $154.1M | $135.7M | $286.3K |
| Liabilities And Stockholders Equity | $4.32B | $4.49B | $4.51B | $5.22B | $5.25B | $1.81B | $546.5M | $369.0M | $310.6K |
| Assets Current | $728.9M | $755.8M | $649.0M | $585.3M | $670.1M | $363.3M | $181.4M | $90.8M | $119.8K |
| Goodwill | $2.54B | $2.68B | $2.72B | $3.55B | $3.51B | $998.8M | $266.8M | $202.4M | $38.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.6M | $32.6M | $30.9M | -$103.4M | $49.7M | $23.1M | $51.7M | $20.9M | |
| Repayments Of Long Term Debt | $250.0M | $423.5M | $95.0M | $20.0M | $827.3M | $547.5M | $237.6M | $24.8M | |
| Prepaid Expense And Other Assets Current | $100.6M | $45.4M | $69.3M | $52.1M | $37.4M | $33.4M | $12.7M | $4.9M | |
| Other Liabilities Current | $30.1M | $26.5M | $10.7M | $19.9M | $43.2M | $89.5M | $17.1M | $14.7M | |
| Other Assets Noncurrent | $19.1M | $17.6M | $21.1M | $22.4M | $15.1M | $16.5M | $6.9M | $5.0M | |
| Minority Interest | $7.8M | $7.0M | $8.2M | $6.6M | $4.8M | -$74.0M | -$14.7M | ||
| Long Term Debt Noncurrent | $1.72B | $1.96B | $2.09B | $2.15B | $2.18B | $776.6M | $395.1M | $127.1M | |
| Long Term Debt Current | $20.3M | $16.3M | $53.4M | $35.0M | $20.0M | $8.1M | $1.7M | $7.1M | |
| Inventory Net | $151.2M | $139.8M | $113.6M | $127.8M | $123.1M | $58.8M | $13.2M | $7.7M | |
| Contract With Customer Liability Current | $59.8M | $34.9M | $38.6M | $31.6M | $31.4M | $11.0M | $9.6M | $7.5M | |
| Accounts Receivable Net Current | $370.9M | $408.0M | $388.9M | $359.1M | $359.9M | $171.1M | $78.6M | $53.0M | |
| Accounts Payable And Accrued Liabilities Current | $553.7M | $438.0M | $392.0M | $337.5M | $358.4M | $254.2M | $102.7M | $85.6M | |
| Other Liabilities Noncurrent | $243.8M | $272.0M | $302.1M | $305.5M | $322.5M | $186.5M | $29.4M | $3.2M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $78.0K | $2.3M | $4.4M | $8.7M | -$2.4M | -$4.4M | $1.4M | ||
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $7.0M | $5.6M | $2.5M | $2.0M | $1.1M | $800.0K | $1.3M | $300.0K | |
| Warrant Liability Noncurrent | $0.00 | $38.5M | $113.9M | $27.6M | $20.0M | ||||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$2.3M | $0.00 | $0.00 | -$20.2M | -$5.3M | -$2.1M | -$1.4M | |
| Supplemental Deferred Purchase Price | $355.0K | $0.00 | $137.0K | $457.0K | $4.5M | $33.0K | $1.6M | $500.0K | |
| Capital Lease Obligations Incurred | $0.00 | $0.00 | $1.3M | $23.0M | $40.0M | $36.3M | $27.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.62B | $1.59B | $1.57B | $1.52B | $1.49B | $1.46B | $1.73B | $2.18B | $2.16B | $2.15B | $2.13B | $2.12B | $1.99B | $1.89B | $1.79B | $315.2M | -$101.3M | -$100.4M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $24.3K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $80.4M | $68.6M | $53.7M | $100.2M | $69.8M | $79.6M | $56.1M | $45.1M | $101.4M | $110.7M | $118.8M | $119.4M | $336.7M | $178.2M | $132.1M | $272.3M | $110.6M | $48.2M | $8.8M | $2.2M | $14.9M | $846.7K | $988.7K | ||||
| Retained Earnings Accumulated Deficit | -$530.2M | -$554.7M | -$569.4M | -$612.4M | -$635.3M | -$654.7M | -$398.1M | $56.0M | $42.0M | $28.9M | $12.8M | -$1.3M | -$66.0M | -$124.1M | -$203.2M | $2.1M | $2.2M | $2.9M | $1.4M | $909.5K | $219.6K | ||||||
| Liabilities | $2.76B | $2.76B | $2.86B | $2.95B | $3.02B | $3.03B | $2.99B | $3.02B | $3.12B | $3.08B | $3.06B | $3.08B | $3.20B | $2.79B | $2.73B | $11.1M | $10.2M | $8.9M | $8.3M | $8.0M | $8.0M | ||||||
| Assets | $4.38B | $4.35B | $4.44B | $4.47B | $4.51B | $4.50B | $4.73B | $5.20B | $5.28B | $5.24B | $5.20B | $5.20B | $5.19B | $4.69B | $4.52B | $256.6M | $255.9M | $255.2M | $253.1M | $252.3M | $251.6M | ||||||
| Liabilities Current | $670.7M | $622.1M | $576.7M | $553.0M | $596.0M | $492.7M | $448.2M | $458.0M | $524.5M | $466.9M | $435.5M | $443.6M | $502.1M | $605.9M | $513.1M | $314.8M | $257.1M | $191.2M | $3.2M | $2.3M | $980.5K | $380.1K | $97.7K | $75.8K | |||
| Liabilities And Stockholders Equity | $4.38B | $4.35B | $4.44B | $4.47B | $4.51B | $4.50B | $4.73B | $5.20B | $5.28B | $5.24B | $5.20B | $5.20B | $5.19B | $4.69B | $4.52B | $1.55B | $739.3M | $661.8M | $256.6M | $255.9M | $255.2M | $253.1M | $252.3M | $251.6M | |||
| Assets Current | $724.8M | $658.0M | $745.2M | $683.8M | $686.4M | $656.0M | $585.1M | $568.3M | $646.7M | $631.9M | $605.2M | $615.0M | $823.4M | $590.9M | $503.5M | $484.4M | $263.6M | $194.5M | $746.6K | $1.0M | $907.0K | $1.1M | $1.3M | $1.3M | |||
| Goodwill | $2.65B | $2.65B | $2.64B | $2.71B | $2.71B | $2.72B | $3.04B | $3.55B | $3.55B | $3.52B | $3.52B | $3.52B | $3.36B | $3.23B | $3.14B | $810.5M | $342.9M | $340.8M | $43.9M | $22.0M | $19.4M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$56.1M | $2.4M | $55.1M | -$30.2M | $32.2M | -$28.7M | -$10.3M | ||||||||||||||||||||
| Repayments Of Long Term Debt | $25.0M | $25.0M | $30.0M | $5.0M | $303.8M | $984.0K | $151.9M | ||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $115.1M | $46.9M | $42.3M | $48.9M | $55.6M | $38.3M | $41.9M | $42.6M | $56.1M | $37.5M | $28.4M | $26.0M | $39.4M | $29.0M | $35.1M | $18.3M | $9.4M | $9.8M | |||||||||
| Other Liabilities Current | $29.0M | $28.9M | $30.7M | $25.8M | $26.4M | $26.2M | $11.1M | $11.7M | $18.8M | $26.9M | $30.1M | $37.6M | $73.4M | $83.9M | $108.3M | $81.1M | $76.4M | $16.5M | |||||||||
| Other Assets Noncurrent | $18.7M | $18.8M | $18.9M | $17.2M | $19.4M | $20.0M | $22.5M | $22.2M | $19.7M | $20.5M | $15.7M | $15.2M | $12.1M | $19.3M | $19.2M | $6.5M | $7.3M | $5.7M | |||||||||
| Minority Interest | $8.1M | $6.7M | $6.1M | $7.9M | $6.8M | $9.2M | $7.3M | $6.1M | $7.6M | $5.6M | $4.5M | $5.3M | $4.3M | $4.1M | $4.2M | -$8.9M | -$15.3M | -$18.8M | |||||||||
| Long Term Debt Noncurrent | $1.74B | $1.79B | $1.94B | $2.01B | $2.04B | $2.16B | $2.13B | $2.14B | $2.17B | $2.16B | $2.17B | $2.18B | $2.19B | $1.78B | $1.75B | $722.7M | $443.2M | $463.6M | |||||||||
| Long Term Debt Current | $16.3M | $16.3M | $16.3M | $16.3M | $40.0M | $40.0M | $40.0M | $40.0M | $40.0M | $30.0M | $25.0M | $20.0M | $20.0M | $96.8M | $17.5M | $8.5M | $2.6M | $2.6M | |||||||||
| Inventory Net | $149.1M | $148.9M | $129.3M | $133.5M | $123.9M | $108.6M | $116.3M | $114.9M | $136.0M | $125.4M | $102.7M | $99.6M | $99.9M | $81.5M | $75.5M | $46.5M | $24.4M | $18.0M | |||||||||
| Contract With Customer Liability Current | $59.9M | $56.3M | $46.5M | $35.8M | $36.2M | $34.0M | $48.0M | $34.7M | $32.4M | $31.6M | $31.4M | $30.6M | $22.3M | $24.9M | $25.2M | $13.2M | $13.5M | $15.6M | |||||||||
| Accounts Receivable Net Current | $380.3M | $393.6M | $418.5M | $401.2M | $437.1M | $429.6M | $370.7M | $365.7M | $353.2M | $358.3M | $355.3M | $369.9M | $347.5M | $302.1M | $260.8M | $147.3M | $119.2M | $118.7M | |||||||||
| Accounts Payable And Accrued Liabilities Current | $521.7M | $477.2M | $421.2M | $430.4M | $446.6M | $340.2M | $314.5M | $337.7M | $401.3M | $346.9M | $315.0M | $316.1M | $312.4M | $350.7M | $305.9M | $192.3M | $142.5M | $136.1M | |||||||||
| Other Liabilities Noncurrent | $244.2M | $244.2M | $244.4M | $272.8M | $275.6M | $275.6M | $302.6M | $302.7M | $302.9M | $306.6M | $309.1M | $314.0M | $314.9M | $317.5M | $322.5M | $71.6M | $45.7M | $36.6M | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $569.0K | $1.2M | $1.6M | $1.6M | $4.8M | $5.2M | $8.4M | $8.3M | $5.9M | $13.0M | $5.2M | $3.6M | -$1.2M | -$1.9M | -$2.5M | -$5.1M | -$5.8M | -$5.1M | |||||||||
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $2.9M | $527.0K | $2.0M | $3.5M | $2.5M | $2.0M | $1.1M | $800.0K | $1.3M | ||||||||||||||||||
| Warrant Liability Noncurrent | $6.6M | $15.8M | $16.6M | $38.5M | $38.8M | $31.0M | $57.8M | $56.5M | $73.3M | $110.7M | $50.9M | $42.1M | $48.5M | ||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$2.3M | $0.00 | -$8.2M | -$7.7M | -$4.2M | -$5.3M | -$2.1M | |||||||||||||||||||
| Supplemental Deferred Purchase Price | $0.00 | $50.0K | $308.0K | $423.0K | $14.0K | ||||||||||||||||||||||
| Capital Lease Obligations Incurred | $0.00 | $1.3M | $7.4M | $9.8M | $8.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $601.8M | $541.8M | $480.7M | $373.9M | $275.7M | $195.6M | $60.4M | $68.4M | |
| Net Cash Provided By Used In Investing Activities | -$303.2M | -$310.3M | -$357.3M | -$411.2M | -$1.82B | -$815.7M | -$84.9M | -$96.3M | |
| Net Cash Provided By Used In Financing Activities | -$302.2M | -$198.9M | -$92.5M | -$66.1M | $1.60B | $643.2M | $76.1M | $48.8M | $119.8K |
| Share Based Compensation | $21.9M | $14.9M | $22.5M | $22.4M | $25.3M | $18.7M | $11.1M | $883.4K | |
| Payments To Acquire Property Plant And Equipment | $382.4M | $306.1M | $337.5M | $391.4M | $203.3M | $39.8M | $21.3M | $9.9M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $61.1M | -$27.3M | $20.3M | $13.1M | -$2.7M | $10.8M | $9.6M | $1.6M | |
| Increase Decrease In Inventories | $11.5M | $28.1M | -$15.5M | $6.3M | $14.9M | $19.4M | $1.3M | -$2.3M | |
| Increase Decrease In Accounts Receivable | -$31.0M | $26.2M | $28.9M | $209.0K | $29.7M | $29.5M | $20.2M | $22.0M | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $139.3M | $33.8M | $41.0M | -$57.1M | -$83.4M | $136.6M | $14.2M | $2.7M | |
| Payments To Acquire Businesses Net Of Cash Acquired | $42.4M | $9.5M | $19.7M | $19.0M | $1.62B | $769.3M | $63.5M | $86.3M | |
| Adjustments Related To Tax Withholding For Share Based Compensation | $2.7M | $2.0M | $5.3M | $4.1M | $3.6M | $284.0K | |||
| Payments To Minority Shareholders | $7.0M | $5.6M | $2.5M | $2.0M | $1.1M | $800.0K | $1.3M | $300.0K | |
| Payments Related To Tax Withholding For Share Based Compensation | $2.7M | $2.1M | $5.8M | $3.5M | $3.6M | $59.0K | $508.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $95.5M | $49.0M | $140.2M | $66.5M | $18.4M | $24.4M | $16.2M | -$380.2K | ||||||||
| Net Cash Provided By Used In Investing Activities | -$95.6M | -$87.9M | -$89.6M | -$80.1M | -$1.21B | -$111.3M | -$26.2M | -$250.0M | ||||||||
| Net Cash Provided By Used In Financing Activities | -$56.0M | $41.3M | $4.4M | -$16.6M | $1.23B | $58.2M | -$368.8K | $251.3M | ||||||||
| Share Based Compensation | $5.3M | $4.5M | $5.9M | $5.5M | $8.6M | $2.2M | $5.2M | |||||||||
| Payments To Acquire Property Plant And Equipment | $95.6M | $87.9M | $89.1M | $77.2M | $35.6M | $7.5M | $5.3M | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$194.0K | -$33.6M | $4.5M | -$12.2M | -$2.6M | -$3.9M | $172.5K | |||||||||
| Increase Decrease In Inventories | -$9.2M | -$5.1M | $8.1M | -$21.3M | -$16.4M | -$51.0K | $161.1K | |||||||||
| Increase Decrease In Accounts Receivable | $15.4M | $40.6M | -$5.9M | $9.5M | $7.3M | $20.5M | $8.6M | |||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.5M | -$65.1M | $54.6M | -$60.6M | -$43.4M | $24.1M | $4.0M | |||||||||
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $447.0K | $2.9M | $1.18B | $105.8M | $20.9M | ||||||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $527.0K | $755.0K | $1.3M | $400.0K | $261.0K | $1.1M | $513.0K | $2.2M | $1.9M | $808.0K | $613.0K | $1.3M | ||||
| Payments To Minority Shareholders | $2.0M | $0.00 | ||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $1.3M | $1.1M | $2.5M | $1.3M | $810.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.52 | $0.61 | -$5.31 | $0.33 | $0.67 | -$3.08 | -$0.95 | -$0.13 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 135.1M | 133.8M | 134.2M | 134.2M | 126.3M | 52.5M | 22.6M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 135.1M | 135.5M | 134.4M | 139.0M | 133.0M | 52.5M | 22.6M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 1.0M | |
| Preferred Stock Shares Outstanding | 124.1K | 124.1K | 124.1K | 124.1K | 163.6K | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 124.1K | 124.1K | 124.1K | 124.1K | 163.6K | 0.00 | 0.00 | ||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 250.0M | 100.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Earnings Per Share Basic | $-0.52 | $0.62 | $-5.06 | $0.47 | $1.12 | $-3.08 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.16 | $0.10 | -$0.05 | $0.15 | $0.13 | -$0.02 | -$3.43 | $0.09 | -$0.06 | $0.11 | $0.09 | $0.08 | $0.20 | $0.12 | -$0.08 | -$0.89 | $0.08 | -$0.82 | -$0.17 | -$0.10 | -$0.01 | -$0.02 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 135.3M | 135.0M | 134.8M | 134.3M | 133.2M | 132.9M | 134.8M | 134.3M | 134.5M | 134.2M | 134.3M | 134.0M | 131.7M | 129.7M | 111.1M | 57.4M | 44.5M | 42.0M | 21.7M | 21.7M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 137.2M | 137.1M | 134.8M | 136.5M | 136.0M | 132.9M | 135.0M | 136.2M | 136.0M | 137.6M | 137.0M | 138.5M | 140.3M | 136.6M | 116.0M | 57.4M | 47.8M | 42.0M | 21.7M | 21.7M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |
| Preferred Stock Shares Outstanding | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 183.6K | 158.1K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 124.1K | 183.6K | 158.1K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 245.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Earnings Per Share Basic | $0.17 | $0.10 | $-0.05 | $0.16 | $0.13 | $-0.02 | $-3.37 | $0.10 | $0.11 | $0.11 | $0.10 | $0.29 | $0.40 | $-0.89 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 | -$2.2M | -$2.1M | -$4.3M | $11.0M | $5.8M | -$10.7M | $2.5M | ||
| Depreciation Expense Excluding Patient Equipment Depreciation | $40.6M | $45.0M | $57.1M | $64.9M | $63.1M | $11.4M | $3.1M | $2.7M | |
| Costs And Expenses | $3.19B | $3.00B | $3.80B | $2.78B | $2.24B | $999.3M | $500.3M | $314.2M | |
| Additional Paid In Capital | $2.18B | $2.16B | $2.15B | $2.13B | $2.11B | $558.5M | $4.4M | $24.3K | |
| Fair Value Adjustment Of Warrants | $0.00 | -$4.0M | -$34.5M | -$17.2M | -$53.2M | $135.4M | $7.7M | ||
| Unrealized Gain Loss On Derivatives | $0.00 | $367.0K | $1.8M | $2.9M | $2.9M | $2.8M | -$11.4M | $546.8K | |
| Interest Paid Net | $101.2M | $122.1M | $126.2M | $108.9M | $73.6M | $35.8M | $23.1M | $7.3M | |
| Capital Expenditures Incurred But Not Yet Paid | $65.9M | $56.1M | $35.9M | $24.2M | $13.9M | $7.9M | $8.5M | $12.6M | |
| Amortization Of Financing Costs | $5.7M | $5.7M | $5.2M | $5.2M | $5.4M | $1.9M | $1.3M | $477.8K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.2M | $999.0K | $2.0M | $1.6M | $1.0M | $101.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $742.0K | $587.0K | $2.5M | $12.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 | -$604.0K | -$405.0K | -$675.0K | -$3.2M | -$364.0K | $856.0K | $66.0K | $2.5M | -$2.8M | $7.8M | $1.6M | $6.0M | $640.0K | $664.0K | $1.9M | $925.0K | -$1.1M | -$11.4M | $850.0K | ||||||
| Depreciation Expense Excluding Patient Equipment Depreciation | $10.1M | $10.2M | $10.4M | $11.3M | $11.4M | $11.4M | $14.5M | $15.5M | $15.5M | $16.2M | $15.9M | $16.1M | $14.7M | $17.9M | $13.4M | $4.1M | $1.0M | $1.2M | $840.0K | $758.0K | $840.7K | ||||
| Costs And Expenses | $758.6M | $753.3M | $754.7M | $742.4M | $753.9M | $742.0M | $1.27B | $739.0M | $718.4M | $703.5M | $668.4M | $654.7M | $577.6M | $551.6M | $466.7M | $271.1M | $216.5M | $183.2M | $127.7M | $109.2M | $114.2M | ||||
| Additional Paid In Capital | $2.17B | $2.17B | $2.16B | $2.15B | $2.16B | $2.15B | $2.15B | $2.14B | $2.14B | $2.13B | $2.12B | $2.11B | $2.06B | $2.02B | $1.99B | $2.9M | $2.8M | $2.1M | $2.9M | $3.6M | $4.1M | $4.8M | |||
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $0.00 | -$2.2M | -$7.0M | $7.5M | -$9.2M | -$812.0K | -$21.9M | $1.4M | $8.2M | -$26.7M | -$16.7M | -$37.5M | -$3.2M | $36.9M | -$654.0K | $36.1M | |||||||
| Unrealized Gain Loss On Derivatives | $0.00 | $367.0K | $579.0K | $726.0K | $709.0K | $707.0K | -$2.7M | ||||||||||||||||||
| Interest Paid Net | $46.0M | $50.3M | $50.1M | $43.9M | $16.2M | $7.7M | $2.8M | ||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $58.3M | $42.1M | $34.9M | $26.2M | $19.2M | $7.8M | $11.1M | ||||||||||||||||||
| Amortization Of Financing Costs | $1.3M | $1.3M | $1.3M | $1.3M | $894.0K | $392.0K | $136.8K | ||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $649.0K | $564.0K | $392.0K | $607.0K | $1.0M | $1.0M | $863.0K | $753.0K | $702.0K | $314.0K | |||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $198.0K | $545.0K | $538.0K | $665.0K | $723.0K | $9.8M | $2.3M |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.